HLN
Haleon Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$9.32
+0.98%Forward multiples
Based on analyst estimates
- P/E forward
- 20.52x
- P/E 2026E
- 16.32x
- P/E 2027E
- 15.18x
- P/E 2028E
- 14.13x
- P/S forward
- 2.95x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.31x
- PEG TTM
- 2.24x
- Price / book
- 1.88x
- Price / sales
- 2.77x
- Price / cash flow
- 13.37x
Enterprise value
- Enterprise value
- $51.0B
- EV / sales
- 3.45x
- EV / EBITDA
- 13.20x
- EV / EBIT
- 15.76x
- Market cap
- $41.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026